Artivion (AORT) Gross Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -244.00 |
| Dec 31, 2025 | -262.00 |
| Sep 30, 2025 | -61.00 |
| Jun 30, 2025 | -203.00 |
| Mar 31, 2025 | -226.00 |
| Dec 31, 2024 | -359.00 |
| Sep 30, 2024 | -292.00 |
| Jun 30, 2024 | -142.00 |
| Mar 31, 2024 | -98.00 |
| Dec 31, 2023 | -143.00 |
| Sep 30, 2023 | -207.00 |
| Jun 30, 2023 | -186.00 |
| Mar 31, 2023 | 123.00 |
| Dec 31, 2022 | -474.00 |
| Sep 30, 2022 | -443.00 |
| Jun 30, 2022 | -387.00 |
| Mar 31, 2022 | 19.00 |
| Dec 31, 2021 | -457.00 |
| Sep 30, 2021 | 37.00 |
| Jun 30, 2021 | 198.00 |
| Mar 31, 2021 | 308.00 |
| Dec 31, 2020 | -88.00 |
| Sep 30, 2020 | 361.00 |
| Jun 30, 2020 | 607.00 |
| Mar 31, 2020 | 836.00 |
| Dec 31, 2019 | 586.00 |
| Sep 30, 2019 | 242.00 |
| Jun 30, 2019 | 149.00 |
| Mar 31, 2019 | 269.00 |
| Dec 31, 2018 | 381.00 |
| Sep 30, 2018 | 171.00 |
| Jun 30, 2018 | 286.00 |
| Mar 31, 2018 | -218.00 |
| Dec 31, 2017 | 467.00 |
| Sep 30, 2017 | 412.00 |
| Jun 30, 2017 | 442.00 |
| Mar 31, 2017 | -42.00 |
| Dec 31, 2016 | 554.00 |
| Sep 30, 2016 | 204.00 |
| Jun 30, 2016 | -50.00 |
| Mar 31, 2016 | 293.00 |
| Dec 31, 2015 | 638.00 |
| Sep 30, 2015 | 910.00 |
| Jun 30, 2015 | -5.00 |